Multiparametric magnetic resonance imaging (mpMRI) is increasingly used in staging early prostate cancer (PCa) but remains heavily reader-dependent. We aim to define the incremental utility of mpMRI over clinical parameters in determining the pathologic extracapsular extension (pECE) of PCa interpreted in a standard radiologic setting and when further over-read by a specialized reader.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
We retrospectively reviewed 120 men with clinically localized PCa undergoing mpMRI and radical prostatectomy. We obtained radiologic prediction of pECE from standard radiologic reports (standard read) and by a specialized reader blinded to clinical and pathologic findings (specialized read). We determined the incremental benefit of standard read and specialized read by sequential addition to a baseline clinical parameters-only logistic regression model predicting pECE. The sensitivity and specificity of standard read were 77% and 44%, respectively, whereas those of specialized read were 86% and 81%. The positive likelihood ratio was 1. 7 at baseline, 1. 7 adding standard read, and 6. 5 adding specialized read. The negative likelihood ratio was 0. 6 at baseline, 0. 5 adding standard read, and 0. 1 adding specialized read. Standard read modestly improved prediction of pECE, whereas specialized read improved it moderately.
PATIENT SUMMARY - The incremental benefit of mpMRI over clinical information is small but increases to moderate with a specialized second opinion. This second opinion may be useful when considering active surveillance, nerve-sparing surgery, or focal therapy.
European urology. 2015 Nov 06 [Epub ahead of print]
Kae Jack Tay, Rajan T Gupta, Alison F Brown, Rachel K Silverman, Thomas J Polascik
Division of Urology, Duke University Medical Center, Durham, NC, USA. Department of Radiology, Duke University Medical Center, Durham, NC, USA. , Department of Radiology, Duke University Medical Center, Durham, NC, USA. , Department of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. , Division of Urology, Duke University Medical Center, Durham, NC, USA.